Redox (ASX: RDX) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Redox Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Redox (ASX: RDX)
Latest News
Cheap Shares
Brokers rate these 2 top ASX shares as buys in January
Dividend Investing
30 ASX shares going ex-dividend next week
IPOs
Fewer ASX IPOs in 2023, but here's how they've performed
Small Cap Shares
The small-cap ASX shares Celeste analysts are 'attracted to' right now
What is capital raising?
RDX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Redox
Redox Ltd. engages in the marketing and distribution of organic & inorganic, ingredient and raw materials. The company's product line includes agriculture, chemical manufacture, detergents, food & beverage, plastic & foam, mining, oil & gas, metals, rubber, textile, building & construction, lubricants, human health, personal care, water treatment and surface coating chemicals. Redox was founded by Coneliano Roland in 1965 and headquartered in Minto, Australia.
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 29 Oct 2025 | Mary Verschuer | Buy | 9,055 | $25,562 |
On-market trade.
|
| 08 Oct 2025 | Raimond Coneliano | Issued | 421,883 | $1,181,272 |
Issue of securities. 1,171,883 LTI Performance Rights
|
| 08 Oct 2025 | Renato Coneliano | Issued | 158,819 | $444,693 |
Issue of securities. 458,819 LTI Performance Rights
|
| 08 Oct 2025 | Renato Coneliano | Issued | 158,819 | $444,693 |
Issue of securities. 458,819 LTI Performance Rights
|
| 08 Oct 2025 | Richard Coneliano | Issued | 161,108 | $451,102 |
Issue of securities. 461,108 LTI Performance Rights
|
| 22 Aug 2025 | Garry Wayling | Buy | 7,670 | $19,946 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Ian Houston Campbell | Non-Executive ChairmanNon-Executive Director | Mar 2009 |
Mr Campbell has 30 years' experience as a Partner of Ernst & Young and predecessor firms. He has served as an Independent Director and Chairman of the Audit Committee on the boards of Gloria Jeans Coffees International Pty Limited, Green's Foods Holdings Pty Limited, Bigstone Capital Pty Limited and Riskflo Associates Limited. He was also a Partner in the board search practice at Talent Partners. He is also a Member of Risk Management Committee and People and Safety Committee
|
| Mr Garry Ronald Wayling | Non-Executive Director | Jun 2023 |
Mr Wayling had 35 years of experience in the professional services sector. He was an Audit Partner for 13 years with Arthur Andersen Sydney and then 8 years as an Audit Partner in the Strategic Growth division at Ernst & Young before retiring from the partnership in 2010. He is Chair of Risk Management Committee and Member of People and Safety Committee.
|
| Ms Mary Joan Verschuer | Non-Executive Director | Jun 2023 |
Ms Verschuer is an experienced Non-Executive Director and Chair with experience in executive leadership roles with responsibility for manufacturing, supply chain management and sales and marketing. She also mentors CEOs with the CEO Institute and Kilfinan Australia. She was the President of the Minerals and Metals division for Schenck Process, a German private equity owned business, and was Vice President of the Asian division of Huhtamaki, a Finnish listed niche packaging business. She is Chair of People and Safety Committee and Member of Risk Management Committee.
|
| Mr Raimond Coneliano | Chief Executive OfficerManaging Director | Nov 2013 |
Mr Coneliano is the Chief Executive Officer and Managing Director after having served as a Director on the Board of Redox since 2013 and sitting on the People and Safety Committee.
|
| Mr Renato Coneliano | Executive DirectorMarketing Director | May 1986 |
Mr Coneliano joined Redox in 1980. He has had many roles over time including both sales and product management responsibilities, as well as Joint Managing Director in 2022. Renato has been a Director of Redox since 1986.
|
| Mr Richard Coneliano | Alternate Director | Sep 2023 |
Mr Coneliano has 30 years of experience as a computer programmer at Redox where he led the development of Redox's integrated ERP/CRM software platform Redebiz. Throughout his career at Redox, Richard has held various positions, including IT Manager for 26 years.
|
| Ms Erika Jasarevic | Company SecretaryGeneral Counsel |
-
|
|
| Richard Coneliano | Alternate Director and Chief Operating Officer |
-
|
|
| Kim Yap | Chief Financial Officer |
-
|
|
| Erika Jasarevic | Company SecretaryGeneral Counsel |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Richard Coneliano | 70,492,961 | 13.43% |
| Robert Coneliano | 53,157,673 | 10.12% |
| J P Morgan Nominees Australia Pty Limited | 45,608,794 | 8.69% |
| Claudia Walters | 41,869,854 | 7.97% |
| Renato Coneliano | 32,048,549 | 6.10% |
| Catherine Coneliano | 31,122,954 | 5.93% |
| Citicorp Nominees Pty Limited | 30,011,944 | 5.72% |
| HSBC Custody Nominees (Australia) Limited | 29,941,530 | 5.70% |
| Kenneth Perrins | 23,275,062 | 4.43% |
| Christopher Perrins | 18,615,606 | 3.55% |
| Cassandra Shoukry | 14,317,153 | 2.73% |
| Raimond Coneliano | 13,003,236 | 2.48% |
| Malcolm Perrins | 10,381,291 | 1.98% |
| UBS Nominees Pty Ltd | 9,747,872 | 1.86% |
| Judith Coneliano | 8,441,428 | 1.61% |
| Peta-Lee Gaida | 5,903,469 | 1.12% |
| Shaun Gaida | 5,903,283 | 1.12% |
| National Nominees Limited | 5,403,578 | 1.03% |
| Alexander Coneliano | 4,551,612 | 0.87% |
| Ivana Coneliano | 4,551,612 | 0.87% |
| Laura Coneliano | 4,551,612 | 0.87% |
| Selina Coneliano | 4,551,612 | 0.87% |
| Tania Coneliano | 4,551,612 | 0.87% |
